Brave Asset Management’s GSK GSK Stock Holding History

Brave Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-364	Closed	-$20K	–	215
2016 Q3	$20K	Hold	364	–	–	0.01%	282
2016 Q2	$20K	Hold	364	–	–	0.01%	288
2016 Q1	$18K	Hold	364	–	–	0.01%	302
2015 Q4	$18K	Hold	364	–	–	0.01%	303
2015 Q3	$17K	Hold	364	–	–	0.01%	296
2015 Q2	$19K	Hold	364	–	–	0.01%	310
2015 Q1	$21K	Hold	364	–	–	0.01%	304
2014 Q4	$19K	Hold	364	–	–	0.01%	314
2014 Q3	$21K	Hold	364	–	–	0.02%	298
2014 Q2	$24K	Hold	364	–	–	0.02%	285
2014 Q1	$24K	Hold	364	–	–	0.02%	279
2013 Q4	$24K	Buy	+364	New	+$23.6K	0.02%	270

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brave Asset Management's GSK Position: Q4 2016 in Review

Brave Asset Management sold out of GSK (GSK) in Q4 2016, closing a stake of 364 shares — an estimated $20K sold.

Brave Asset Management first reported a position in GSK in Q4 2013 and held it in 12 quarters. The position peaked at $24K in Q2 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Brave Asset Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 364 GSK shares in Q4 2016, an estimated $20K.
Brave Asset Management first reported a position in GSK in Q4 2013 and held it in 12 quarters.
Brave Asset Management's GSK position peaked at $24K in Q2 2014.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.